Neuropeptides and hippocampal neurogenesis

Neuropeptides

Volumn 47, Issue 6, 2013, Pages 431-438

  Zaben, M J ^a   Gray, W P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Galanin; Hippocampus; Neurogenesis; NPY and learning and memory; VIP

Indexed keywords

GALANIN; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

BEHAVIOR; DENTATE GYRUS; HIPPOCAMPUS; INTRACELLULAR SIGNALING; LEARNING; MEMORY; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

GALANIN; HIPPOCAMPUS; NEUROGENESIS; NPY AND LEARNING AND MEMORY; VIP;

ANIMALS; GALANIN; HIPPOCAMPUS; HUMANS; LEARNING; MEMORY; MICE; NEUROGENESIS; NEUROPEPTIDE Y; NEUROPEPTIDES; RATS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84887990077     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2013.10.002     Document Type: Review

References (115)

1. Abbosh C., Lawkowski A., et al. GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. J. Neurochem. 2011, 117(3):425-436.
2. Acsady L., Gorcs T.J., et al. Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience 1996, 73(2):317-334.
3. Altar C.A., Laeng P., et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 2004, 24(11):2667-2677.
4. Alvaro A.R., Martins J., et al. Neuropeptide Y stimulates retinal neural cell proliferation-involvement of nitric oxide. J. Neurochem. 2008, 105(6):2501-2510.
5. Basille M., Vaudry D., et al. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. J. Comput. Neurol. 2000, 425(4):495-509.
6. Berg D.A., Belnoue L., et al. Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain. Development 2013, 140(12):2548-2561.
7. Blondel O., Collin C., et al. A glia-derived signal regulating neuronal differentiation. J. Neurosci. 2000, 20(21):8012-8020.
8. Bouchard P., Maurice T., et al. Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. Eur. J. Neurosci. 1997, 9(10):2142-2151.
9. Branchek T.A., Smith K.E., et al. Galanin receptor subtypes. Trends Pharmacol. Sci. 2000, 21(3):109-117.
10. Brenneman D.E., Glazner G., et al. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide. Ann. N.Y. Acad. Sci. 1998, 865:207-212.
11. Brezun J.M., Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999, 89(4):999-1002.
12. Brezun J.M., Daszuta A. Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons. Eur. J. Neurosci. 2000, 12(1):391-396.
13. Caberlotto L., Jimenez P., et al. Alterations in neuropeptide Y levels and Y1 binding sites in the flinders sensitive line rats, a genetic animal model of depression. Neurosci. Lett. 1999, 265(3):191-194.
14. Calegari F., Haubensak W., et al. Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J. Neurosci. 2005, 25(28):6533-6538.
15. Carvajal C.C., Vercauteren F., et al. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behav. Brain Res. 2004, 153(2):471-480.
16. Cha C.I., Lee Y.I., et al. Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. Brain Res. 1997, 753(2):235-244.
17. Chen G., Rajkowska G., et al. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 2000, 75(4):1729-1734.
18. Cheung A., Newland P.L., et al. Intracellular nitric oxide mediates neuroproliferative effect of neuropeptide y on postnatal hippocampal precursor cells. J. Biol. Chem. 2012, 287(24):20187-20196.
19. Colmers W.F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 1994, 17(9):373-379.
20. Crawley J.N. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease. Cell. Mol. Life Sci. 2008, 65(12):1836-1841.
21. Dayer A.G., Ford A.A., et al. Short-term and long-term survival of new neurons in the rat dentate gyrus. J. Comput. Neurol. 2003, 460(4):563-572.
22. de Lanerolle N.C., Gunel M., et al. Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy. Brain Res. 1995, 686(2):182-193.
23. Decressac M., Wright B., et al. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 2011, 21(3):233-238.
24. Deisseroth K., Singla S., et al. Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron 2004, 42(4):535-552.
25. DiCicco-Bloom E. "Region-specific regulation of neurogenesis by VIP and PACAP: direct and indirect modes of action". Ann. N.Y. Acad. Sci. 1996, 805:244-256. discussion 256-248.
26. DiCicco-Bloom E., Deutsch P.J., et al. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development. Dev. Biol. 2000, 219(2):197-213.
27. Eilam R., Davidson A., et al. Locomotor activity causes a rapid up-regulation of vasoactive intestinal peptide in the rat hippocampus. Hippocampus 1999, 9(5):534-541.
28. Elliott-Hunt C.R., Marsh B., et al. Galanin acts as a neuroprotective factor to the hippocampus. Proc. Natl. Acad. Sci. USA 2004, 101(14):5105-5110.
29. Encinas J.M., Vaahtokari A., et al. Fluoxetine targets early progenitor cells in the adult brain. Proc. Natl. Acad. Sci. USA 2006, 103(21):8233-8238.
30. Flood J.F., Morley J.E. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides 1989, 10(5):963-966.
31. Flood J.F., Hernandez E.N., et al. Modulation of memory processing by neuropeptide Y. Brain Res. 1987, 421(1-2):280-290.
32. Floren A., Land T., et al. Galanin receptor subtypes and ligand binding. Neuropeptides 2000, 34(6):331-337.
33. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996, 6(4):347-470.
34. Fukuda S., Kato F., et al. Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J. Neurosci. 2003, 23(28):9357-9366.
35. Ge S., Pradhan D.A., et al. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci. 2007, 30(1):1-8.
36. Glowa J.R., Panlilio L.V., et al. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 1992, 570(1-2):49-53.
37. Gould E., Gross C.G. Neurogenesis in adult mammals: some progress and problems. J. Neurosci. 2002, 22(3):619-623.
38. Gould E., Vail N., et al. Adult-generated hippocampal and neocortical neurons in macaques have a transient existence. Proc. Natl. Acad. Sci. USA 2001, 98(19):10910-10917.
39. Gozes I., McCune S.K., et al. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 1991, 257(3):959-966.
40. Gozes I., Glowa J., et al. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 1993, 4(3):185-193.
41. Gressens P., Paindaveine B., et al. Growth factor properties of VIP during early brain development. Whole embryo culture and in vivo studies. Ann. N.Y. Acad. Sci. 1997, 814:152-160.
42. Gressens P., Paindaveine B., et al. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur. J. Neurosci. 1998, 10(5):1734-1742.
43. Hansel D.E., Eipper B.A., et al. Neuropeptide Y functions as a neuroproliferative factor. Nature 2001, 410(6831):940-944.
44. Hansel D.E., Eipper B.A., et al. Regulation of olfactory neurogenesis by amidated neuropeptides. J. Neurosci. Res. 2001, 66(1):1-7.
45. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38(4):213-224.
46. Heilig M., Wahlestedt C., et al. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmacol. 1988, 147(3):465-467.
47. Heilig M., Soderpalm B., et al. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 1989, 98(4):524-529.
48. Higuchi H., Yang H.Y., et al. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood. J. Neurochem. 1988, 50(6):1879-1886.
49. Hill J.M., Cuasay K., et al. Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring. Exp. Neurol. 2007, 206(1):101-113.
50. Hill J.M., Hauser J.M., et al. Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry. J. Mol. Neurosci. 2007, 31(3):183-200.
51. Hokfelt T. Galanin and its receptors: introduction to the third international symposium, San Diego, California, USA, 21-22 October 2004. Neuropeptides 2005, 39(3):125-142.
52. Hokfelt T., Johansson O., et al. Chemical anatomy of the brain. Science 1984, 225(4668):1326-1334.
53. Howell O.W., Scharfman H.E., et al. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J. Neurochem. 2003, 86(3):646-659.
54. Howell O.W., Doyle K., et al. Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J. Neurochem. 2005, 93(3):560-570.
55. Howell O.W., Silva S., et al. Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus. Neurobiol. Dis. 2007, 26(1):174-188.
56. Husum H., Mathe A.A. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology 2002, 27(5):756-764.
57. Husum H., Mikkelsen J.D., et al. Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 2000, 39(8):1463-1473.
58. Karlsson R.M., Choe J.S., et al. "The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice". Psychopharmacology 2007, (Berl.).
59. Katsetos C.D., Del Valle L., et al. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch. Pathol. Lab. Med. 2001, 125(5):613-624.
60. Kempermann G. Why new neurons? Possible functions for adult hippocampal neurogenesis. J. Neurosci. 2002, 22(3):635-638.
61. Kempermann G., Kuhn H.G., et al. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997, 386(6624):493-495.
62. Ko F.J., Chiang C.H., et al. Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders. Gaoxiong Yi Xue Ke Xue Za Zhi 1991, 7(8):391-397.
63. Kohler C. Distribution and morphology of vasoactive intestinal polypeptide-like immunoreactive neurons in regio superior of the rat hippocampal formation. Neurosci. Lett. 1982, 33(3):265-270.
64. Kopp J., Xu Z.Q., et al. Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 2002, 111:443-532.
65. Kronenberg G., Reuter K., et al. Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli. J. Comput. Neurol. 2003, 467(4):455-463.
66. Kuteeva E., Calza L., et al. Distribution of galanin in the brain of a galanin-overexpressing transgenic mouse. Neuropeptides 2005, 39(3):293-298.
67. Leranth C., Frotscher M., et al. Ultrastructure and synaptic connections of vasoactive intestinal polypeptide-like immunoreactive non-pyramidal neurons and axon terminals in the rat hippocampus. Neuroscience 1984, 12(2):531-542.
68. Li B.S., Ma W., et al. Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. J. Neurosci. 2001, 21(5):1569-1579.
69. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem. Pharmacol. 1998, 56(3):269-277.
70. Lopez-Tellez J.F., Vela J., et al. Postnatal development of the alpha1 containing GABAA receptor subunit in rat hippocampus. Brain Res. Dev. Brain Res. 2004, 148(1):129-141.
71. Loren I., Emson P.C., et al. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience 1979, 4(12):1953-1976.
72. Madsen T.M., Treschow A., et al. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry 2000, 47(12):1043-1049.
73. Malberg J.E., Eisch A.J., et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20(24):9104-9110.
74. Maslov A.Y., Barone T.A., et al. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J. Neurosci. 2004, 24(7):1726-1733.
75. Mazarati A., Lu X., et al. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience 2004, 128(2):431-441.
76. Moody T.W., Hill J.M., et al. VIP as a trophic factor in the CNS and cancer cells. Peptides 2003, 24(1):163-177.
77. Morgan C.A., Wang S., et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol. Psychiatry 2000, 47(10):902-909.
78. Morgan C.A., Rasmusson A.M., et al. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol. Psychiatry 2002, 52(2):136-142.
79. Ogren S.O., Kuteeva E., et al. Galanin receptor antagonists: a potential novel pharmacological treatment for mood disorders. CNS Drugs 2006, 20(8):633-654.
80. Ogren S.O., Kuteeva E., et al. Neuropeptides in learning and memory processes with focus on galanin. Eur. J. Pharmacol. 2010, 626(1):9-17.
81. Olson A.K., Eadie B.D., et al. Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways. Hippocampus 2006, 16(3):250-260.
82. Ostenfeld T., Svendsen C.N. Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells 2004, 22(5):798-811.
83. Palmer T.D., Takahashi J., et al. The adult rat hippocampus contains primordial neural stem cells. Mol. Cell. Neurosci. 1997, 8(6):389-404.
84. Parent J.M., Valentin V.V., et al. Prolonged seizures increase proliferating neuroblasts in the adult rat subventricular zone-olfactory bulb pathway. J. Neurosci. 2002, 22(8):3174-3188.
85. Parker R.M.C., Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 1999, 11:1431-1448.
86. Pinhasov A., Mandel S., et al. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res. Dev. Brain Res. 2003, 144(1):83-90.
87. Pirondi S., Fernandez M., et al. The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J. Neurochem. 2005, 95(3):821-833.
88. Prickaerts J., Koopmans G., et al. Learning and adult neurogenesis: survival with or without proliferation?. Neurobiol. Learn. Mem. 2004, 81(1):1-11.
89. Redrobe J.P., Dumont Y., et al. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 2002, 26(5):615-624.
90. Redrobe J.P., Dumont Y., et al. Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J. Mol. Neurosci. 2004, 22(3):159-166.
91. Riquelme P.A., Drapeau E., et al. "Brain micro-ecologies: neural stem cell niches in the adult mammalian brain". Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007.
92. Rostene W.H., Fischette C.T., et al. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus. J. Neurosci. 1983, 3(12):2414-2419.
93. Sajdyk T.J., Vandergriff M.G., et al. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 1999, 368(2-3):143-147.
94. Santarelli L., Saxe M., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301(5634):805-809.
95. Seaberg R.M., van der Kooy D. Adult rodent neurogenic regions: the ventricular subependyma contains neural stem cells, but the dentate gyrus contains restricted progenitors. J. Neurosci. 2002, 22(5):1784-1793.
96. Shen Q., Zhong W., et al. Asymmetric numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts. Development 2002, 129(20):4843-4853.
97. Shen P.J., Larm J.A., et al. Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression. Eur. J. Neurosci. 2003, 18(6):1362-1376.
98. Sheward W.J., Lutz E.M., Harmar A.J. The distribution of vasoactive intestinal peptide2 receptor messenger RNA in the rat brain and pituitary gland assessed by in situ hybridization. Neuroscience 1995, 67:409-418.
99. Shors T.J. Memory traces of trace memories: neurogenesis, synaptogenesis and awareness. Trends Neurosci. 2004, 27(5):250-256.
100. Shors T.J., Miesegaes G., et al. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410(6826):372-376.
101. Sisti H.M., Glass A.L., et al. Neurogenesis and the spacing effect: learning over time enhances memory and the survival of new neurons. Learn Mem. 2007, 14(5):368-375.
102. Sloviter R.S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 1994, 35(6):640-654.
103. Song J., Zhong C., et al. Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature 2012, 489(7414):150-154.
104. Swanson C.J., Blackburn T.P., et al. Anxiolytic and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc. Natl. Acad. Sci. USA 2005, 102(48):17489-17494.
105. Thorsell A., Michalkiewicz M., et al. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. USA 2000, 97(23):12852-12857.
106. Tozuka Y., Fukuda S., et al. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005, 47(6):803-815.
107. Usdin T.B., Bonner T.I., et al. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 1994, 135(6):2662-2680.
108. Vaudry D., Gonzalez B.J., et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 2000, 52(2):269-324.
109. Villuendas G., Sanchez-Franco F., et al. Involvement of VIP on BDNF-induced somatostatin gene expression in cultured fetal rat cerebral cortical cells. Brain Res. Mol. Brain Res. 2001, 94(1-2):59-66.
110. Wahlestedt C., Pich E.M., et al. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 1993, 259(5094):528-531.
111. Wang H.L., Li A., et al. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res. 1997, 746(1-2):294-300.
112. Wang L.P., Kempermann G., et al. A subpopulation of precursor cells in the mouse dentate gyrus receives synaptic GABAergic input. Mol. Cell. Neurosci. 2005, 29(2):181-189.
113. Westrin A., Ekman R., et al. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur. Neuropsychopharmacol. 1999, 9(3):205-211.
114. Wu J.Y., Henins K.A., et al. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides 1997, 18(8):1131-1137.
115. Zaben M., Sheward W.J., et al. The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors. Stem Cells 2009, 27(10):2539-2551.